42 related articles for article (PubMed ID: 12901837)
1. Ribosomal protein SA is a common component of neuronal intranuclear inclusions in polyglutamine diseases and Marinesco bodies.
Yagita K; Sadashima S; Koyama S; Noguchi H; Hamasaki H; Sasagasako N; Honda H
Neuropathology; 2024 Feb; 44(1):31-40. PubMed ID: 37340992
[TBL] [Abstract][Full Text] [Related]
2. RNA Foci Formation in a Retinal Glial Model for Spinocerebellar Ataxia Type 7.
Suárez-Sánchez R; Ávila-Avilés RD; Hernández-Hernández JM; Sánchez-Celis D; Azotla-Vilchis CN; Gómez-Macías ER; Leyva-García N; Ortega A; Magaña JJ; Cisneros B; Hernández-Hernández O
Life (Basel); 2022 Dec; 13(1):. PubMed ID: 36675972
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-Modulated Phase Separation of Shuttle Proteins: Does Condensate Formation Promote Protein Degradation?
Dao TP; Castañeda CA
Bioessays; 2020 Nov; 42(11):e2000036. PubMed ID: 32881044
[TBL] [Abstract][Full Text] [Related]
4. Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.
Niewiadomska-Cimicka A; Trottier Y
Neurotherapeutics; 2019 Oct; 16(4):1074-1096. PubMed ID: 31432449
[TBL] [Abstract][Full Text] [Related]
5. PML Bodies in Mitosis.
Lång A; Lång E; Bøe SO
Cells; 2019 Aug; 8(8):. PubMed ID: 31416160
[TBL] [Abstract][Full Text] [Related]
6. SUMOylation by SUMO2 is implicated in the degradation of misfolded ataxin-7 via RNF4 in SCA7 models.
Marinello M; Werner A; Giannone M; Tahiri K; Alves S; Tesson C; den Dunnen W; Seeler JS; Brice A; Sittler A
Dis Model Mech; 2019 Jan; 12(1):. PubMed ID: 30559154
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome Profiling Identifies Multiplexin as a Target of SAGA Deubiquitinase Activity in Glia Required for Precise Axon Guidance During Drosophila Visual Development.
Ma J; Brennan KJ; D'Aloia MR; Pascuzzi PE; Weake VM
G3 (Bethesda); 2016 Aug; 6(8):2435-45. PubMed ID: 27261002
[TBL] [Abstract][Full Text] [Related]
8. PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.
Sahin U; de Thé H; Lallemand-Breitenbach V
Nucleus; 2014; 5(6):499-507. PubMed ID: 25482067
[TBL] [Abstract][Full Text] [Related]
9. A cellular system that degrades misfolded proteins and protects against neurodegeneration.
Guo L; Giasson BI; Glavis-Bloom A; Brewer MD; Shorter J; Gitler AD; Yang X
Mol Cell; 2014 Jul; 55(1):15-30. PubMed ID: 24882209
[TBL] [Abstract][Full Text] [Related]
10. Calpain 5 is highly expressed in the central nervous system (CNS), carries dual nuclear localization signals, and is associated with nuclear promyelocytic leukemia protein bodies.
Singh R; Brewer MK; Mashburn CB; Lou D; Bondada V; Graham B; Geddes JW
J Biol Chem; 2014 Jul; 289(28):19383-94. PubMed ID: 24838245
[TBL] [Abstract][Full Text] [Related]
11. PML in the Brain: From Development to Degeneration.
Korb E; Finkbeiner S
Front Oncol; 2013 Sep; 3():242. PubMed ID: 24062991
[TBL] [Abstract][Full Text] [Related]
12. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.
Reichelt M; Wang L; Sommer M; Perrino J; Nour AM; Sen N; Baiker A; Zerboni L; Arvin AM
PLoS Pathog; 2011 Feb; 7(2):e1001266. PubMed ID: 21304940
[TBL] [Abstract][Full Text] [Related]
13. The role of PML in the nervous system.
Salomoni P; Betts-Henderson J
Mol Neurobiol; 2011 Apr; 43(2):114-23. PubMed ID: 21161613
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease.
Shishido-Hara Y
Acta Neuropathol; 2010 Sep; 120(3):403-17. PubMed ID: 20464404
[TBL] [Abstract][Full Text] [Related]
15. Ataxin-1 fusion partners alter polyQ lethality and aggregation.
Rich T; Varadaraj A
PLoS One; 2007 Oct; 2(10):e1014. PubMed ID: 17925862
[TBL] [Abstract][Full Text] [Related]
16. PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins.
Janer A; Martin E; Muriel MP; Latouche M; Fujigasaki H; Ruberg M; Brice A; Trottier Y; Sittler A
J Cell Biol; 2006 Jul; 174(1):65-76. PubMed ID: 16818720
[TBL] [Abstract][Full Text] [Related]
17. A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein.
Qin Q; Inatome R; Hotta A; Kojima M; Yamamura H; Hirai H; Yoshizawa T; Tanaka H; Fukami K; Yanagi S
J Cell Biol; 2006 Feb; 172(4):497-504. PubMed ID: 16461359
[TBL] [Abstract][Full Text] [Related]
18. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.
McFadden K; Hamilton RL; Insalaco SJ; Lavine L; Al-Mateen M; Wang G; Wiley CA
J Neuropathol Exp Neurol; 2005 Jun; 64(6):545-52. PubMed ID: 15977647
[TBL] [Abstract][Full Text] [Related]
19. PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases.
Takahashi J; Fujigasaki H; Iwabuchi K; Bruni AC; Uchihara T; El Hachimi KH; Stevanin G; Dürr A; Lebre AS; Trottier Y; de Thé H; Tanaka J; Hauw JJ; Duyckaerts C; Brice A
Neurobiol Dis; 2003 Aug; 13(3):230-7. PubMed ID: 12901837
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
